Literature DB >> 24185118

Value of calretinin immunostaining in diagnostic pathology: a review and update.

Nelson G Ordóñez1.   

Abstract

Calretinin is a member of the EF-hand family of calcium-binding proteins. Because its expression is highly restricted to mesotheliomas, calretinin is, at present, the most commonly used positive mesothelioma marker that is most often recommended to be included in the various immunohistochemical panels used to assist in the differential diagnosis of these tumors. Calretinin expression has also been reported to be commonly expressed in a wide variety of other neoplasms, including sex cord-stromal tumors, adrenal cortical neoplasms, olfactory neuroblastomas, Schwann cell tumors, cardiac myxomas, and ameloblastomas. This article reviews the information that is currently available on calretinin expression in tumors and on its application as an immunohistochemical marker in diagnostic pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24185118     DOI: 10.1097/PAI.0b013e31829b6fbd

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  9 in total

1.  Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.

Authors:  Donata Micello; Alberto Bossi; Alessandro Marando; Emanuele Dainese; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2017-05-26       Impact factor: 4.064

2.  Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System.

Authors:  Kay J Park; Vance Broach; Dennis S Chi; Irina Linkov; Frank Z Stanczyk; Prusha Patel; Anjali Jotwani; Celeste Leigh Pearce; Malcolm C Pike; Noah D Kauff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

3.  Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.

Authors:  Kay J Park; Prusha Patel; Irina Linkov; Anjali Jotwani; Noah Kauff; Malcolm C Pike
Journal:  Histopathology       Date:  2018-01-29       Impact factor: 5.087

4.  Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.

Authors:  Jelena Kresoja-Rakic; Merve Sulemani; Michaela B Kirschner; Manuel Ronner; Glen Reid; Steven Kao; Beat Schwaller; Walter Weder; Rolf A Stahel; Emanuela Felley-Bosco
Journal:  Front Genet       Date:  2017-05-29       Impact factor: 4.599

5.  Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.

Authors:  Jelena Kresoja-Rakic; Esra Kapaklikaya; Gabriela Ziltener; Damian Dalcher; Raffaella Santoro; Brock C Christensen; Kevin C Johnson; Beat Schwaller; Walter Weder; Rolf A Stahel; Emanuela Felley-Bosco
Journal:  Oncotarget       Date:  2016-04-19

6.  Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study.

Authors:  Swaantje Casjens; Daniel G Weber; Georg Johnen; Irina Raiko; Dirk Taeger; Carmen Meinig; Susanne Moebus; Karl-Heinz Jöckel; Thomas Brüning; Beate Pesch
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

7.  Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Authors:  Guadalupe Aguilar-Madrid; Beate Pesch; Emma S Calderón-Aranda; Katarzyna Burek; Carmina Jiménez-Ramírez; Cuauhtémoc Arturo Juárez-Pérez; María Dolores Ochoa-Vázquez; Luis Torre-Bouscoulet; Leonor Concepción Acosta-Saavedra; Isabel Sada-Ovalle; Jorge García-Figueroa; Isabel Alvarado-Cabrero; Patricia Castillo-González; Alejandra Renata Báez-Saldaña; José Rogelio Pérez-Padilla; Juvencio Osnaya-Juárez; Rosa María Rivera-Rosales; Eric Marco García-Bazán; Yolanda Lizbeth Bautista-Aragón; Elimelec Lazcano-Hernandez; Daniel Alejandro Munguía-Canales; Luis Marcelo Argote-Greene; Dirk Taeger; Daniel Gilbert Weber; Swaantje Casjens; Irina Raiko; Thomas Brüning; Georg Johnen
Journal:  Int J Med Sci       Date:  2018-06-04       Impact factor: 3.738

Review 8.  Application of immunohistochemistry in diagnosis and management of malignant mesothelioma.

Authors:  David B Chapel; Jefree J Schulte; Aliya N Husain; Thomas Krausz
Journal:  Transl Lung Cancer Res       Date:  2020-02

9.  Calretinin expression in odontogenic cysts and odontogenic tumors and the possible role of calretinin in pathogenesis of ameloblastoma.

Authors:  Amrutha Rudraraju; Aparna Venigalla; Suresh Babburi; Pinnisetti Soujanya; R V Subramanyam; K Roja Lakshmi
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.